An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP

Clinical trial NCT00508820 · COMPLETED

Trial details

NCT number: NCT00508820
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura Thrombocytopenia Thrombocytopenic Purpura

Start date: 2005-02-01
Primary completion: 2011-01-01
Enrollment: 407

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.